SCI-110 for Alzheimer Disease and Agitation

Clinical trial NCT05239390 · UNKNOWN

Trial details

NCT number: NCT05239390
Sponsor: The Israeli Medical Center for Alzheimer's
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-12-29
Primary completion: 2023-06-29
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.